MGMT and neoplasm: The prevalence of MGMT promoter hypermethylation in non-neoplastic diseases could reflect a broader epigenetic landscape influencing cellular responses to stress or injury, as supported by findings that suggest altered methylation patterns can impact gene expression and cellular functions in a variety of neurological conditions [46].